Mostrar el registro sencillo del ítem
A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain)
dc.contributor.author | Solorzano Puerto, Antonio | |
dc.contributor.author | Gutiérrez Fernández, José | |
dc.contributor.author | Fernández, F. | |
dc.contributor.author | Soto, M.J. | |
dc.contributor.author | Piédrola Angulo, Gonzalo | |
dc.date.accessioned | 2024-03-22T10:39:51Z | |
dc.date.available | 2024-03-22T10:39:51Z | |
dc.date.issued | 2004-02 | |
dc.identifier.citation | SORLÓZANO, A., GUTIÉRREZ, J., FERNÁNDEZ, F., SOTO, M., & PIÉDROLA, G. (2004). A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain). Annals of Microbiology, 54(2), 227-232. | es_ES |
dc.identifier.uri | https://hdl.handle.net/10481/90198 | |
dc.description.abstract | - A preliminary study was conducted to detect extended spectrum beta-lacta mases (ESBLs) and to describe ESBL types in clinical isolates of Escherichia coli from Granada (Spain). Sixty-two isolates were examined using the VITEK 2 system, disk dif fusion method and Epsilon test. Fourteen randomly selected isolates were subjected to genetic analysis in order to detect the ESBL type (CTX-M-10, CTX-M-9 and SHV). ESBL isoelectric points were determined by isoelectric focusing using crude extracts from soni cated cells. Out of the 62 isolates with ESBLs detected by the VITEK 2 system, 61 (98.4%) were confirmed to contain ESBLs by disk diffusion and/or Epsilon test. The pre valent ESBL type in E. coli was CTX-M-9. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Annals of microbiology | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Enterobacteriaceae | es_ES |
dc.subject | Beta-lactamases | es_ES |
dc.subject | Antimicrobial agent | es_ES |
dc.title | A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain) | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |